InsightRX Nova Precision Dosing in Clinical Trials

Maximize Clinical Trial Success with MIPD

Empower your biopharma company to integrate precision dosing into clinical trials with a quality-compliant, end-to-end dosing platform.

InsightRX Nova

Core features and capabilities

dose-protocol-reference-table
dose-protocol-reference-table

Increase program success with precision dosing intelligence

Plan and execute drug optimization strategies starting in Phase I. Leverage model-informed precision dosing (MIPD), Bayesian forecasting, and machine learning to test multiple dose ranges for easy identification of target dose levels and intervals.

trial-monitoring-and-patient-summary

Maximize drug efficacy and safety for participants

Avoid sub-therapeutic and supra-therapeutic dosing by targeting specific drug exposures or biomarker ranges. InsightRX Nova accounts for individual concentration levels, lab results, and patient demographics — helping to sidestep risks associated with maximum tolerated dose (MTD)-based regimens.

trial-monitoring-and-patient-summary
PKPD-model-parameters
PKPD-model-parameters

Boost patient enrollment and retention in trials

High variability and adverse drug reactions can drive patient dropout, costing organizers up to 30% of enrollees and significant financial impact.

Precision dosing supports therapeutic target achievement and uses real-time drug response predictions to identify vulnerable patients early—reducing adverse events and improving retention.

Additional Information

Learn more about our products and services: